Inozyme Pharma, Inc. (INZY)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

321 SUMMER STREET BOSTON, MA 02210

Inozyme Pharma is a rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases of abnormal mineralization. Through the company's in-depth understanding of the biological pathways involved in mineralization, company is pursuing the development of therapeutics to address the underlying causes of these debilitating diseases. It is well established that two genes, ENPP1 and ABCC6, play key roles in a critical mineralization pathway and that defects in these genes lead to abnormal mineralization. Inozyme is initially focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies.

Data as of 2021-08-02 09:15:07 -0400
Market Cap393.811 Million Shares Outstanding23.483 Million Avg 30-day Volume66.993 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-1.01 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.96619 52-week High/Low31.65 / 14.51 Next Earnings Date2021-08-12 Price to Cash FLow (P/CF) -36.1772
Data provided by IEX Cloud
View SEC Filings from INZY instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 3 4 -25.0% 2 (0.12%) 2 (0.12%) 0.0%
Funds Holding: 56 55 1.82% 18 (1.06%) 19 (1.1%) -5.26%
13F shares: 19.164 Million 18.361 Million 4.37% 10.717 Million 9.685 Million 10.66%
% Ownership 81.6756 78.5589 3.97% 45.6723 41.4357 10.22%
New Positions: 6 11 -45.45% 2 3 -33.33%
Increased Positions 21 20 5.0% 6 6 0.0%
Closed Positions 5 10 -50.0% 3 4 -25.0%
Reduced Positions 11 7 57.14% 4 4 0.0%
Total Calls
Total Puts
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding INZY (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding INZY BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

66.8 Thousand total shares from 1 transactions

Exercise Derivative Conversion (M)

66.8 Thousand total shares from 1 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BOLTE AXEL CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
291,305 2021-06-24 3

DIAZ REINALDO M

  • Director
9,367 2021-06-23 1

MATHERS EDWARD T

  • Director
9,367 2021-06-23 1

HOPFNER ROBERT LORNE

  • Director
9,367 2021-06-23 1

EDWARDS MARTIN

  • Director
9,367 2021-06-23 1

TRECO DOUGLAS A

  • Director
9,367 2021-06-23 1

SULLIVAN LYNNE MARIE

  • Director
9,367 2021-06-23 1

BHAGAT SARAH M

  • Director
9,367 2021-06-23 1

INOZYME PHARMA, INC.

  • Director
9,367 2021-06-23 1

DIPALMA STEPHEN J. INTERIM CFO

  • Officer
0 2021-05-17 2

BASSO STEPHEN SVP FINANCE (PFO)

  • Officer
13,000 2021-03-24 3

BJARKE HENRIC BJORN SVP, COO

  • Officer
51,000 2021-03-04 2

JUNGLES STEVEN J SVP, CTO

  • Officer
42,000 2021-03-04 2

WENKERT DEBORAH SVP, CMO

  • Officer
0 2021-02-02 2

NOVO HOLDINGS A/S

  • 10% Owner
No longer subject to file 2021-01-28 1

HUERTAS PEDRO SVP, CMO

  • Officer
0 2021-01-13 1

SANOFI

  • 10% Owner
No longer subject to file 2020-07-28 0

SOFINNOVA VENTURE PARTNERS X, L.P.

SOFINNOVA MANAGEMENT X, L.L.C.

HEALY JAMES

KATABI MAHA

POWELL MICHAEL

  • 10% Owner
No longer subject to file 2020-07-28 0

MAKOWER JOSHUA

  • 10% Owner
2,437,689 2020-07-28 0

SANDELL SCOTT D

  • 10% Owner
2,437,689 2020-07-28 0

LONGITUDE CAPITAL PARTNERS III, LLC

LONGITUDE VENTURE PARTNERS III, L.P.

TAMMENOMS BAKKER JULIET

ENRIGHT PATRICK G

  • 10% Owner
2,819,379 2020-07-28 0

BASKETT FOREST

  • 10% Owner
2,437,689 2020-07-28 0

RA CAPITAL MANAGEMENT, L.P.

KOLCHINSKY PETER

SHAH RAJEEV M.

  • 10% Owner
No longer subject to file 2020-07-28 0

SONSINI PETER W.

  • 10% Owner
2,437,689 2020-07-28 0

FLORENCE ANTHONY A. JR.

  • 10% Owner
2,437,689 2020-07-28 0

ROCK SPRINGS CAPITAL MANAGEMENT LP

ROCK SPRINGS CAPITAL MASTER FUND LP

ROCK SPRINGS CAPITAL LLC

  • 10% Owner
No longer subject to file 2020-07-28 0

NEW ENTERPRISE ASSOCIATES 15, L.P.

NEA PARTNERS 15, L.P.

NEA 15 GP, LLC

  • 10% Owner
2,437,689 2020-07-28 0

MAKHZOUMI MOHAMAD

  • 10% Owner
2,437,689 2020-07-28 0

SCHLESSINGER JOSEPH

  • 10% Owner
No longer subject to file 2020-07-28 0

ALEXION PHARMACEUTICALS, INC.

  • 10% Owner
No longer subject to file 2020-07-28 0

PIVOTAL BIOVENTURE PARTNERS FUND I, L.P.

PIVOTAL BIOVENTURE PARTNERS FUND I G.P., L.P.

PIVOTAL BIOVENTURE PARTNERS FUND I U.G.P., LTD

  • 10% Owner
No longer subject to file 2020-07-28 0

BRADDOCK DEMETRIOS

  • 10% Owner
381,650 2020-07-23 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

BOLTE AXEL - Director - Officer CHIEF EXECUTIVE OFFICER

2021-06-25 07:58:07 -0400 2021-06-24 M 66,788 $0.98 a 257,613 direct -1.0619 0.295 0.885 5 -1.0619 2

BOLTE AXEL - Director - Officer CHIEF EXECUTIVE OFFICER

2021-06-25 07:58:07 -0400 2021-06-24 M 66,788 d 100,480 direct

BOLTE AXEL - Director - Officer CHIEF EXECUTIVE OFFICER

2021-06-25 07:58:07 -0400 2021-06-24 S 66,788 $0.00 d 190,825 direct -1.0619 0.295 0.885 5 -1.0619 2

INOZYME PHARMA, INC. - Director

2021-06-24 16:10:00 -0400 2021-06-23 A 9,367 a 9,367 direct

TRECO DOUGLAS A - Director

2021-06-24 16:16:03 -0400 2021-06-23 A 9,367 a 9,367 direct

DIAZ REINALDO M - Director

2021-06-24 16:11:00 -0400 2021-06-23 A 9,367 a 9,367 direct

BHAGAT SARAH M - Director

2021-06-25 07:48:26 -0400 2021-06-23 A 9,367 a 9,367 direct

EDWARDS MARTIN - Director

2021-06-24 16:17:09 -0400 2021-06-23 A 9,367 a 9,367 direct

HOPFNER ROBERT LORNE - Director

2021-06-24 16:12:21 -0400 2021-06-23 A 9,367 a 9,367 direct

MATHERS EDWARD T - Director

2021-06-24 17:32:26 -0400 2021-06-23 A 9,367 a 9,367 direct

SULLIVAN LYNNE MARIE - Director

2021-06-24 16:14:52 -0400 2021-06-23 A 9,367 a 9,367 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
INOZYME PHARMA INC INZY 2021-08-05 22:15:04 UTC -0.5771 0.6571 5000
INOZYME PHARMA INC INZY 2021-08-05 21:45:03 UTC -0.5771 0.6571 5000
INOZYME PHARMA INC INZY 2021-08-05 21:15:03 UTC -0.5771 0.6571 5000
INOZYME PHARMA INC INZY 2021-08-05 20:45:03 UTC -0.5771 0.6571 5000
INOZYME PHARMA INC INZY 2021-08-05 20:15:04 UTC -0.5771 0.6571 5000
INOZYME PHARMA INC INZY 2021-08-05 19:45:04 UTC -0.5771 0.6571 5000
INOZYME PHARMA INC INZY 2021-08-05 19:15:03 UTC -0.5771 0.6571 5000
INOZYME PHARMA INC INZY 2021-08-05 18:45:03 UTC -0.5771 0.6571 5000
INOZYME PHARMA INC INZY 2021-08-05 18:15:03 UTC -0.5771 0.6571 5000
INOZYME PHARMA INC INZY 2021-08-05 17:45:03 UTC -0.5771 0.6571 5000
INOZYME PHARMA INC INZY 2021-08-05 17:15:03 UTC -0.5771 0.6571 5000
INOZYME PHARMA INC INZY 2021-08-05 16:45:02 UTC -0.5771 0.6571 5000
INOZYME PHARMA INC INZY 2021-08-05 16:15:03 UTC -0.5771 0.6571 5000
INOZYME PHARMA INC INZY 2021-08-05 15:45:03 UTC -0.5771 0.6571 5000
INOZYME PHARMA INC INZY 2021-08-05 15:15:02 UTC -0.5771 0.6571 5000
INOZYME PHARMA INC INZY 2021-08-05 14:45:02 UTC -0.5771 0.6571 5000
INOZYME PHARMA INC INZY 2021-08-05 14:15:04 UTC -0.5771 0.6571 5000
INOZYME PHARMA INC INZY 2021-08-05 13:45:04 UTC -0.5771 0.6571 5000
INOZYME PHARMA INC INZY 2021-08-05 13:15:03 UTC -0.5771 0.6571 5000
INOZYME PHARMA INC INZY 2021-08-05 12:45:03 UTC -0.5771 0.6571 5000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments